ATE529413T1 - Verfahren zur synthese von aryloxydiaminopyrimidinen - Google Patents

Verfahren zur synthese von aryloxydiaminopyrimidinen

Info

Publication number
ATE529413T1
ATE529413T1 AT06778311T AT06778311T ATE529413T1 AT E529413 T1 ATE529413 T1 AT E529413T1 AT 06778311 T AT06778311 T AT 06778311T AT 06778311 T AT06778311 T AT 06778311T AT E529413 T1 ATE529413 T1 AT E529413T1
Authority
AT
Austria
Prior art keywords
aryloxydiaminopyrimidines
synthesis
compound
formula
treating
Prior art date
Application number
AT06778311T
Other languages
English (en)
Inventor
Anton Constantinescue
Keena Lynn Green
Gary R Lee
Patrick Finbar Mcgarry
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE529413T1 publication Critical patent/ATE529413T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT06778311T 2005-09-01 2006-08-21 Verfahren zur synthese von aryloxydiaminopyrimidinen ATE529413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71328005P 2005-09-01 2005-09-01
PCT/EP2006/065523 WO2007025898A1 (en) 2005-09-01 2006-08-21 Process for synthesis of aryloxy diaminopyrimidines

Publications (1)

Publication Number Publication Date
ATE529413T1 true ATE529413T1 (de) 2011-11-15

Family

ID=37086108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778311T ATE529413T1 (de) 2005-09-01 2006-08-21 Verfahren zur synthese von aryloxydiaminopyrimidinen

Country Status (9)

Country Link
US (1) US7741484B2 (de)
EP (1) EP1926716B1 (de)
JP (1) JP4820873B2 (de)
CN (1) CN101253158B (de)
AT (1) ATE529413T1 (de)
CA (1) CA2620033C (de)
ES (1) ES2374750T3 (de)
TW (1) TW200738650A (de)
WO (1) WO2007025898A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008002731A (es) * 2005-09-01 2008-03-26 Hoffmann La Roche Diaminopirimidinas como moduladores de p2x3 y p3x2/3.
AU2007304280B2 (en) * 2006-10-04 2013-01-31 F. Hoffmann-La Roche Ag Process for synthesis of phenoxy diaminopyrimidine derivatives
CN102351655A (zh) * 2011-08-18 2012-02-15 杭州澳赛诺化工有限公司 一种4-异丙基间苯二酚的合成方法
AU2014308606B2 (en) * 2013-08-23 2017-08-03 Afferent Pharmaceuticals Inc. Diaminopyrimidine P2X3 and P2X 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough
US10195198B2 (en) 2014-07-03 2019-02-05 Afferent Pharmaceuticals, Inc. Methods and compositions for treating diseases and conditions
DK3355889T3 (da) 2015-09-29 2023-05-15 Afferent Pharmaceuticals Inc Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
EP3784242A4 (de) * 2018-04-23 2021-12-22 Merck Sharp & Dohme Corp. Neuartiges verfahren zur herstellung einer phenoxydiaminopyrimidin-verbindung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE293608T1 (de) * 1999-04-15 2005-05-15 Basf Ag Verfahren zur herstellung von substituierten pyrimidinen
CA2557372C (en) * 2004-03-05 2013-01-08 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 antagonists
MX2008002731A (es) * 2005-09-01 2008-03-26 Hoffmann La Roche Diaminopirimidinas como moduladores de p2x3 y p3x2/3.

Also Published As

Publication number Publication date
CN101253158A (zh) 2008-08-27
CN101253158B (zh) 2013-07-10
CA2620033A1 (en) 2007-03-08
CA2620033C (en) 2014-12-02
WO2007025898A1 (en) 2007-03-08
EP1926716B1 (de) 2011-10-19
JP4820873B2 (ja) 2011-11-24
EP1926716A1 (de) 2008-06-04
JP2009506997A (ja) 2009-02-19
ES2374750T3 (es) 2012-02-21
TW200738650A (en) 2007-10-16
US20070049751A1 (en) 2007-03-01
US7741484B2 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
RU2012103850A (ru) Би-арил-мета-пиримидиновые ингибиторы киназ
EA200702413A1 (ru) Способ получения 1-алкил-3-фенилурацилов
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
EA201100093A1 (ru) Тиадиазолилоксифениламидины и применение их в качестве фунгицидов
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
GB0412769D0 (en) Organic compounds
TW200732335A (en) Organic compounds
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
EA200701707A1 (ru) Пиразолопиримидины
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
DE602006017918D1 (de) Verfahren zur Herstellung von Telmisartan
TW200732337A (en) Organic compounds
ATE525364T1 (de) Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE496914T1 (de) Verfahren zur synthese von triazolen
TW200612959A (en) Method for preparing hydroxamic acids
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties